Peptide Compass · Research
Epitalon: research, prices and suppliers
A synthetic tetrapeptide, studied in aging research as a research substance related to cellular aging.
Epitalon is a synthetic tetrapeptide developed by Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. It is studied in preclinical research in connection with cellular aging and the regulation of telomerase activity. Robust clinical data in humans is still pending.
Facts
- CAS number: 307297-39-8
- Molecular weight: 390.35 g/mol
- Amino acids: 4
- Purity specification: ≥ 98 % (HPLC, commercial standard)
Evidence
- In human fetal fibroblast cell cultures, epitalon induced expression of the catalytic telomerase subunit and measurable telomerase activity, associated with telomere elongation. Khavinson VKh, Bondarev IE, Butyugov AA 2003, Bulletin of Experimental Biology and Medicine 135:590-592
- In animal models, effects of epitalon on melatonin release and on immune system parameters have been described, with mixed results on lifespan depending on the model and protocol used. Khavinson VKh, Morozov VG 2003, Neuroendocrinology Letters
Frequently asked questions
Has epitalon been studied in humans?
Available data come predominantly from cell culture and animal models. Controlled clinical studies in humans meeting Western standards are not yet available.
What does epitalon have to do with telomeres?
Cell culture studies observed an increase in telomerase activity and telomere elongation. Whether this translates to the whole organism remains open.
Is epitalon legally available in Germany?
Epitalon is not approved as a medication and is offered exclusively as a research chemical, not for human use.
Documented prices
Prices are recorded snapshots. Each entry states its date, currency and pack variant. Shipping, tax treatment, discount conditions and availability must be rechecked in the shop. A low price is not evidence of quality.
List prices excluding shipping and discounts. Currency and product variants must be compared separately. Availability and delivered batch have not been verified.
| Vendor | Pack | List price | Price/mg | Recorded | Source |
|---|---|---|---|---|---|
| Peptide Labz | 10 mg | 35 EUR | 3.5 EUR/mg | 2026-09-15 | Product page · Ad |
| Bio BoostX | 10 mg | 35.95 EUR | 3.6 EUR/mg | 2026-09-15 | Product page · Ad |
| Beyond Peptides | 10 mg | 38.81 EUR | 3.88 EUR/mg | 2026-09-15 | Product page · Ad |
| Peak Peptide | 10 mg | 39.9 EUR | 3.99 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptidwerk | 10 mg | 39.95 EUR | 4.0 EUR/mg | 2026-09-15 | Product page · Ad |
| Particle Peptides | 10 mg | 45.99 EUR | 4.6 EUR/mg | 2026-09-15 | Product page · Ad |
| DN Lab Research | 30 mg | 160 EUR | 5.33 EUR/mg | 2026-09-15 | Product page · Ad |
| ELYVERA (Europeptides) | 50 mg | 59.9 EUR | 1.2 EUR/mg | 2026-09-15 | Product page · Ad |
| Peptidwerk | 50 mg | 109.95 EUR | 2.2 EUR/mg | 2026-09-15 | Product page · Ad |
| Chameleon Peptides | 10 mg | 30 USD | 3.0 USD/mg | 2026-09-15 | Product page · Ad |
| Hydro Research Peptides | 10 mg | 44.99 USD | 4.5 USD/mg | 2026-09-15 | Source |
| American Peptides | 10 mg | 60 USD | 6.0 USD/mg | 2026-09-15 | Product page · Ad |
| Licensed Peptides | 10 mg | 91.99 USD | 9.2 USD/mg | 2026-09-15 | Product page · Ad |
Questions about interpretation
What does the search “Epitalon protocol” mean?
“Protocol” is often used to mean a regimen. This page explains research and documented listings. It contains no doses, cycles or instructions for human use. An online regimen is not scientifically validated simply because it is widely shared.
Sources and data basis
These references come from the existing dataset. A link alone verifies neither a study claim nor supplier quality. Uncertainty remains explicit where records are undated or incomplete.
- Khavinson VKh, Bondarev IE, Butyugov AA 2003, Bulletin of Experimental Biology and Medicine 135:590-592
- Khavinson VKh, Morozov VG 2003, Neuroendocrinology Letters
Where to go next
Created with AI assistance. This new edition has not yet received independent editorial review.